Platelets in wound healing and regenerative medicine
Author:
Top Cited Papers
- 14 February 2018
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 29 (6) , 556-568
Abstract
Although platelets are widely recognized as having a critical role in primary hemostasis and thrombosis, increasing experimental and clinical evidence identifies these enucleated cells as relevant modulators of other physiopathological processes including inflammation and tissue regeneration. These phenomena are mediated through the release of growth factors, cytokines, and extracellular matrix modulators that sequentially promote (i) revascularization of damaged tissue through the induction of migration, proliferation, differentiation, and stabilization of endothelial cells in new blood vessels; (ii) restoration of damaged connective tissue through migration, proliferation, and activation of fibroblasts; and (iii) proliferation and differentiation of mesenchymal stem cells into tissue-specific cell types. For these reasons, platelet-rich plasma (PRP) derivatives are used in regenerative medicine for the treatment of several clinical conditions including ulcers, burns, muscle repair, bone diseases, and tissue recovery following surgery. The benefits of PRP administration are associated with an economical advantage, taking into consideration that PRP administration does not require complex equipment or training for its execution. Moreover, due to their primary autologous origin, concerns of disease transmission or immunogenic reactions can be disregarded. Thus, platelet-enriched materials have become highly relevant in the last decade and constitute a growing focus of experimental and clinical study in the context of wound healing and tissue regeneration. However, despite the diverse applications, the efficacy of regenerative treatments using PRP is being called into question due to the lack of large controlled clinical trials and the lack of consensus regarding the PRP preparation techniques. This review describes the biological mechanisms underlying PRP's regenerative effects, the different methods of preparation and application of these biomaterials, and the controversies and future prospects related to the use of PRP in regenerative medicine.Keywords
Funding Information
- Fondo para la Investigación Científica y Tecnológica (PICT 0152-2015,PICT 0352-2014,PICT 1859–2015)
- Fundación Alberto J. Roemmers (Research Grant 2015–2016)
- L’Oréal Foundation-UNESCO FWIS
This publication has 129 references indexed in Scilit:
- Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritisArchives of orthopaedic and trauma surgery, 2016
- Pain in donor site after BTB-ACL reconstruction with PRGF: a randomized trialArchives of orthopaedic and trauma surgery, 2016
- Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trialArchives of orthopaedic and trauma surgery, 2015
- Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled studyInternational Orthopaedics, 2013
- Bone marrow mesenchymal stem cells, platelet-rich plasma and nanohydroxyapatite-type I collagen beads were integral parts of biomimetic bone substitutes for bone regenerationJournal of Tissue Engineering and Regenerative Medicine, 2012
- Induction of Dermal Collagenesis, Angiogenesis, and Adipogenesis in Human Skin by Injection of Platelet-Rich Fibrin MatrixArchives of Facial Plastic Surgery, 2012
- Platelet gel in the treatment of severe scleroderma skin ulcersRheumatology International, 2011
- Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical studyKnee Surgery, Sports Traumatology, Arthroscopy, 2011
- Enhancement of vascularization and granulation tissue formation by growth factors in human platelet‐rich plasma‐containing fragmin/protamine microparticlesJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2011
- Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defectInternational Orthopaedics, 2009